2019 annual financial data

Keros Therapeutics 2019 Net margin

Direct answer

Net margin was -123.44%.

Operating income was -10.56M USD and net income was -12.34M USD.
Operating cash flow was -16M USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10M USD
Operating income
-10.56M USD
Net income
-12.34M USD
Operating cash flow
-16M USD